303 employees
Kerecis is a commercial stage company pioneering the use of fish skin and fatty acids in cellular-therapy and regenerative-medicine
2011
$60M
from 6 investors over 6 rounds
Kerecis raised $60M on July 21, 2022
Investors: Emerson Collective and KIRKBI A/S
Kerecis raised $16M on June 13, 2019
Investors: Curae Lab, Alvogen, Novator Partners Llp and Emerson Collective